AVX001
AVX001 is an inhibitor of phospholipase A2 (cPLA2α) that can be used in the research of psoriasis[1].
Product Specifications
CAS Number
300553-18-8
Product Name Alternative
AKH-217
UNSPSC
12352100
Target
Phospholipase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/avx001.html
Smiles
O=C(CSC/C=C/CC/C=C\C/C=C\C/C=C\C/C=C\CC)C(F)(F)F
Molecular Formula
C21H29F3OS
Molecular Weight
386.51
References & Citations
[1]S H Omland, et al. A randomized, double-blind, placebo-controlled, dose-escalation first-in-man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis. J Eur Acad Dermatol Venereol. 2017 Jul;31 (7) :1161-1167.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP06789PU-N 100 µg
alpha 1b Adrenergic Receptor (ADRA1B) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
